Scenario 3: A user expects 6 doses from a vial but sees 5 in the calculator
Retatrutide Regulatory Status Retatrutide occupies a unique position because it is not yet FDA-approved: Not FDA-approved currently in Phase 3 clinical trials with Eli Lilly No prescription pathway in the US yet no Mounjaro/Wegovy equivalent for retatrutide Legal as research chemical sold in the US for in-vitro and animal research under research-use-only labeling Likely to receive FDA approval in coming years if clinical trial endpoints meet expectations WADA status currently not specifically listed, though peptide hormones generally fall under WADA categories Not DEA-scheduled no controlled substance status Unlike semaglutide and tirzepatide, retatrutide does not yet exist as a prescription drug
Possible Side Effects: Nausea, vomiting, diarrhea, constipation, and reduced appetite may occur
Benefits Supports fuller-, thicker-, healthier-looking hair Helps reduce visible shedding and fallout Nourishes and strengthens strands prone to breakage Deeply hydrates dry, stressed hair without heaviness Supports scalp health for healthier-looking hair growth Leaves hair softer, shinier, and more resilient Helps anchor hair at the root with daily scalp care Designed to support hair wellness during your GLP-1 journey Safe for color-treated and chemically treated hair Salon-quality Key Ingredients Procapil: A clinically studied blend that helps strengthen and anchor hair at the root to reduce fallout and support fuller-looking hair
It has various physiological functions, such as promoting insulin secretion and synthesis, stimulating -cell proliferation, inducing islet regeneration, inhibiting -cell apoptosis and glucagon release, delaying gastric emptying and controlling appetite, etc
GLP-1 side effects tend to be worst during the first few weeks of treatment or after dose increases, then gradually improve as the body adjusts
